meglumine has been researched along with Glioma in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (27.59) | 18.2507 |
| 2000's | 10 (34.48) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, CE; Brady-Kalnay, SM; Clark, H; Darrah, RJ; Drumm, ML; Erokwu, BO; Flask, CA; Griswold, MA; Gu, Y; Hu, H; Johansen, M; Kavran, M; Li, M; Steinmetz, NF; Vincent, J; Yu, X; Zhang, Y | 1 |
| Kim, HS; Kim, JY; Park, JE; Shim, WH | 1 |
| Ahlawat, S; Beniwal, M; Gupta, PK; Gupta, RK; Patir, R; Sahoo, P; Saini, J; Santosh, V; Singh, A; Thennarasu, K | 1 |
| Bowden, SG; Bruce, JN; Canoll, P; Chow, DS; Englander, ZK; Grinband, J; Horenstein, CI; Lignelli, A; Otten, ML | 1 |
| Bobacka, J; Ek, P; Frantzén, J; Gardberg, M; Kiviniemi, A; Minn, H | 1 |
| Ducot, B; Ducreux, D; Lacroix, C; Saliou, G; Vandendries, C | 1 |
| Bozzetti, F; Crisi, G; Erb, G; Filice, S | 1 |
| Attenberger, UI; Jackson, CB; Michaely, HJ; Morelli, JN; Runge, VM; Williams, J | 1 |
| Kramer, H; Loynachan, AT; Naul, LG; Reiser, MF; Runge, VM; Wintersperger, BJ | 1 |
| Abud, L; Capelle, L; Chiras, J; Costalat, R; Guillevin, R; Habas, C; Hoang-Xuan, K; Menuel, C; Vallée, JN | 1 |
| De Keyzer, F; De Vleeschouwer, S; Himmelreich, U; Peeters, RR; Sijbers, J; Sunaert, S; Van Calenbergh, F; Van Cauter, S; Van Gool, SW; Van Hecke, W; Veraart, J | 1 |
| Barreau, X; Colosimo, C; Gérardin, E; Guézénoc, F; Kirchin, MA; Knopp, MV; Lodemann, KP | 1 |
| Jansen, O | 1 |
| Baumann, SS; Biswas, J; Herborn, CU; Jackson, CB; Patel, T; Runge, VM; Wintersperger, BJ | 1 |
| Anzalone, N; Bowen, BC; Essig, M; Gustafsson, L; Knopp, MV; Kuhn, MJ; Maldjian, JA; Maravilla, KR; Picozzi, P; Runge, VM; Schmalfuss, IM; Wippold, FJ; Wolansky, LJ | 1 |
| Callot, V; Cozzone, P; Figarella-Branger, D; Galanaud, D; Lefur, Y; Metellus, P; Nicoli, F | 1 |
| Karttunen, A; Koivukangas, J; Vaara, T; Yrjänä, SK | 1 |
| Cornu, P; Dormont, D; Foncin, JF; Krief, O; Marsault, C; Monnier, L | 1 |
| Cha, SH; Chang, KH; Han, MC; Han, MH; Kim, HD; Ra, DG | 1 |
| Hayashi, N; Ishii, Y; Itoh, S; Iwasaki, T; Kimura, H; Kubota, T; Maeda, M; Yamamoto, K | 1 |
| Barkley, GL; Mehta, BA; Sanders, WP; Silbergleit, R; Spickler, EM | 1 |
| Bruening, R; Cher, L; Harsh, GR; Hochberg, FH; Kwong, KK; Niemi, PT; Rosen, BR; Vevea, MJ; Weisskoff, RM | 1 |
| Aronen, HJ; Jääskeläinen, J; Peltonen, TK; Ruhala, MT; Sepponen, R; Sipilä, LM; Tanttu, JI | 1 |
| Brochard, T; Charvet, AM; Collomb, A; Corde, S; Elleaume, H; Estève, F; Fiedler, S; Le Bas, JF; Le Duc, G | 1 |
| Aube, C; Burtin, P; Caron-Poitreau, C; Haba, D; Pasco Papon, A; Tanguy, JY | 1 |
| Essig, M; Hartmann, M; Jansen, O; Knopp, MV; Lodemann, KP; Runge, VM; Seeberg, A | 1 |
| Matsumura, A; Nose, T; Shimojo, N; Yamamoto, T; Yoshida, F; Zhang, T | 1 |
| Altman, NR; Bilaniuk, LT; Braffman, BH; Brody, BA; Naidich, TP; Post, MJ; Quencer, RM; Zimmerman, RA | 1 |
| Agnoli, AL; Herrmann, S | 1 |
2 review(s) available for meglumine and Glioma
| Article | Year |
|---|---|
MultiHance in brain tumor imaging.
Topics: Brain; Brain Neoplasms; Contrast Media; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Meglumine; Organometallic Compounds | 2004 |
MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review.
Topics: Adolescent; Adult; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Tuberous Sclerosis | 1992 |
5 trial(s) available for meglumine and Glioma
| Article | Year |
|---|---|
Comparison of Dynamic Contrast-Enhancement Parameters between Gadobutrol and Gadoterate Meglumine in Posttreatment Glioma: A Prospective Intraindividual Study.
Topics: Adult; Aged; Contrast Media; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Reproducibility of Results; Young Adult | 2020 |
Effectiveness of a high relaxivity contrast agent administered at half dose in dynamic susceptibility contrast MRI of brain gliomas.
Topics: Adult; Brain Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2017 |
A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours.
Topics: Aged; Brain Neoplasms; Contrast Media; Cross-Over Studies; Double-Blind Method; Female; Glioma; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Sensitivity and Specificity | 2004 |
Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Contrast Media; Cross-Over Studies; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results | 2007 |
[Comparison of contrast behavior of gadobenate-dimeglumine and Gd-DTPA in intra-axial brain tumors. A double-blind randomized intraindividual cross-over study].
Topics: Brain; Brain Neoplasms; Contrast Media; Cross-Over Studies; Double-Blind Method; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Meglumine; Observer Variation; Organometallic Compounds | 2001 |
22 other study(ies) available for meglumine and Glioma
| Article | Year |
|---|---|
Dynamic, Simultaneous Concentration Mapping of Multiple MRI Contrast Agents with Dual Contrast - Magnetic Resonance Fingerprinting.
Topics: Animals; Cell Line, Tumor; Contrast Media; Female; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Meglumine; Mice; Mice, Nude; Neoplasms, Experimental; Organometallic Compounds | 2019 |
Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Contrast Media; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Grading; Organometallic Compounds; Retrospective Studies | 2018 |
Extent of BOLD Vascular Dysregulation Is Greater in Diffuse Gliomas without Isocitrate Dehydrogenase 1 R132H Mutation.
Topics: Biomarkers, Tumor; Brain Neoplasms; Contrast Media; Echo-Planar Imaging; Female; Glioma; Humans; Image Enhancement; Isocitrate Dehydrogenase; Male; Meglumine; Middle Aged; Mutation; Organometallic Compounds; Retrospective Studies | 2018 |
Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
Topics: Brain; Brain Neoplasms; Contrast Media; Female; Gadolinium DTPA; Glioma; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2019 |
Statistical analysis of multi-b factor diffusion weighted images can help distinguish between vasogenic and tumor-infiltrated edema.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Brain Edema; Brain Neoplasms; Contrast Media; Data Interpretation, Statistical; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Meglumine; Middle Aged; Neoplasm Grading; Organometallic Compounds; Sensitivity and Specificity | 2014 |
Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chelating Agents; Disease Models, Animal; Gadolinium DTPA; Glioma; Humans; Ions; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats; Rats, Inbred F344 | 2010 |
Brain MRI with single-dose (0.1 mmol/kg) Gadobutrol at 1.5 T and 3 T: comparison with 0.15 mmol/kg Gadoterate meglumine.
Topics: Animals; Brain; Brain Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Female; Glioma; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas.
Topics: Adult; Brain Neoplasms; Contrast Media; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Neoplasm Grading; Organometallic Compounds; Prospective Studies; Protons; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric; World Health Organization | 2012 |
Gliomas: diffusion kurtosis MR imaging in grading.
Topics: Adult; Aged; Anisotropy; Area Under Curve; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Meglumine; Middle Aged; Neoplasm Grading; Organometallic Compounds; Prospective Studies; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric | 2012 |
The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Topics: Animals; Brain Neoplasms; Contrast Media; Female; Gadolinium DTPA; Glioma; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Random Allocation; Rats; Rats, Inbred F344 | 2006 |
Correlations between MR and endothelial hyperplasia in low-grade gliomas.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Endothelium, Vascular; Female; Glioma; Humans; Hyperplasia; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Statistics, Nonparametric | 2007 |
Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths.
Topics: Adult; Brain Neoplasms; Computer Simulation; Contrast Media; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Models, Theoretical; Organometallic Compounds | 2008 |
MR of isolated leptomeningeal glioma.
Topics: Adult; Biopsy; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Meglumine; Meningeal Neoplasms; Meninges; Organometallic Compounds; Pentetic Acid | 1994 |
Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
Topics: Adolescent; Adult; Aged; Artifacts; Brain; Brain Neoplasms; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Meningioma; Middle Aged; Neurilemmoma; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1994 |
Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging.
Topics: Adolescent; Adult; Aged; Astrocytoma; Blood Volume; Brain Neoplasms; Cerebellar Neoplasms; Child; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Glioma; Hemangiosarcoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Efficacy of gadolinium administration in magnetic resonance imaging screening of patients with complex partial seizures and results of a normal neurologic examination.
Topics: Adult; Brain; Brain Neoplasms; Cerebellar Neoplasms; Contrast Media; Drug Combinations; Electroencephalography; Epilepsy, Complex Partial; Gadolinium; Gadolinium DTPA; Glioma; Hemangioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Meningeal Neoplasms; Meningioma; Neurologic Examination; Organometallic Compounds; Pentetic Acid; Prospective Studies; Temporal Lobe | 1995 |
Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
Topics: Adult; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Drug Combinations; Echo-Planar Imaging; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Injections, Intravenous; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Pentetic Acid; Tomography, Emission-Computed | 1996 |
Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.
Topics: Brain; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid | 1996 |
Feasibility of synchrotron radiation computed tomography on rats bearing glioma after iodine or gadolinium injection. Jeune Equipe RSRM-UJF.
Topics: Animals; Brain Neoplasms; Contrast Media; Feasibility Studies; Female; Gadolinium; Glioma; Ioxaglic Acid; Meglumine; Organometallic Compounds; Rats; Rats, Wistar; Synchrotrons; Tomography, X-Ray Computed; Tumor Cells, Cultured | 2000 |
Use of half-dose gadolinium-enhanced MRI and magnetization transfer saturation in brain tumors.
Topics: Adult; Aged; Brain; Brain Edema; Brain Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Female; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Meningeal Neoplasms; Meningioma; Middle Aged; Organometallic Compounds; Sensitivity and Specificity | 2001 |
Comparison of gadobenate dimeglumine and gadopentetate dimeglumine: a study of MR imaging and inductively coupled plasma atomic emission spectroscopy in rat brain tumors.
Topics: Animals; Brain; Brain Neoplasms; Contrast Media; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Metabolic Clearance Rate; Organometallic Compounds; Rats; Rats, Inbred F344; Spectrophotometry, Atomic | 2002 |
[Contrast medium assisted nuclear magnetic resonance tomography. Signal intensity of gliomatous tumors].
Topics: Astrocytoma; Brain; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Meglumine; Neoplasm Staging; Oligodendroglioma; Organometallic Compounds; Pentetic Acid; Sorbitol | 1990 |